Related Experiment Video

Updated: Nov 18, 2025

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.2K

A policy analysis of the national phenylketonuria screening program in Iran

Alireza Heidari1, Mohammad Arab2, Behzad Damari3

  • 1Health Management and Social Development Research Center, Golestan University of Medical Sciences (GOUMS), Golha Alley, Gorgan, Iran. alirezaheidari7@gmail.com.

BMC Health Services Research
|February 6, 2021
PubMed

Insights

Iran's national phenylketonuria (PKU) screening program faced barriers like milk shortages and low awareness. Policy improvements require stable management, resources, family education, and stakeholder commitment for successful PKU diagnosis and treatment.

Area of Science:

  • Public Health Policy
  • Genetics Screening Programs
  • Healthcare Management

Background:

  • Phenylketonuria (PKU) screening is crucial for early diagnosis and preventing neurological damage.
  • Analyzing the policies of Iran's national PKU screening (NaPS) program provides insights into public health implementation.

Purpose of the Study:

  • To analyze the policy components of Iran's national PKU screening (NaPS) program using the policy triangle model.
  • Identify facilitators and barriers in the implementation of the NaPS program.

Main Methods:

  • Policy analysis utilizing the policy triangle model.
  • Data collection through document review and 38 semi-structured interviews.
  • Content analysis for documents and framework analysis for interviews.

Main Results:

  • The NaPS program was initiated by the Ministry of Health and Medical Education (MOHME) with stakeholder involvement and evidence-based policies.
  • Implementation was driven by parental persistence and executive support, despite opposition and insufficient resources.
  • Key barriers included management turnover, Phe-free milk shortages, low family awareness, social stigma, and hospital administrator cooperation.

Conclusions:

  • The policy triangle framework effectively explains the NaPS program's components.
  • Enhancing the program requires stable leadership, adequate resources (human and Phe-free milk), improved family education, and committed hospital administrators.
  • Effective stakeholder engagement is vital for the success of PKU screening programs.
Abstract

Keywords:
National PKU screening (NaPS)Neonatal screeningPhenylketonuria (PKU)Policy analysisPolicy triangulation framework

More Related Videos

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol12:21

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

10.8K
The Neuroblast Assay: An Assay for the Generation and Enrichment of Neuronal Progenitor Cells from Differentiating Neural Stem Cell Progeny Using Flow Cytometry15:40

The Neuroblast Assay: An Assay for the Generation and Enrichment of Neuronal Progenitor Cells from Differentiating Neural Stem Cell Progeny Using Flow Cytometry

Published on: April 22, 2012

15.8K

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
523
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
77
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
2.9K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
72